Cargando…

KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53/GSK3β signaling

Colorectal cancer (CRC) is the most frequently diagnosed cancer of the digestive tract. Chemotherapy drugs such as oxaliplatin are frequently administered to CRC patients diagnosed with advanced or metastatic disease. A deep understanding of the molecular mechanism underlying CRC tumorigenesis and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yan, Yang, Leping, Xiong, Li, Wang, Kunpeng, Hou, Xuyang, Li, Qinglong, Kong, Fanhua, Liu, Xi, He, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120193/ https://www.ncbi.nlm.nih.gov/pubmed/33995648 http://dx.doi.org/10.7150/jca.52103

Ejemplares similares

HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3
por: Hou, Xuyang, et al.
Publicado: (2020)

Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines
por: Yang, Chao, et al.
Publicado: (2016)

Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer
por: Neska-Długosz, Izabela, et al.
Publicado: (2021)

The AKT/GSK3β-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1
por: Wei, Wei, et al.
Publicado: (2020)

Downregulation of the Helicase Lymphoid-Specific (HELLS) Gene Impairs Cell Proliferation and Induces Cell Cycle Arrest in Colorectal Cancer Cells
por: Liu, Xi, et al.
Publicado: (2019)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

Expression of circZNF609 is Down-Regulated in Colorectal Cancer Tissue and Promotes Apoptosis in Colorectal Cancer Cells by Upregulating p53
por: Zhang, Xiaoyun, et al.
Publicado: (2019)

Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin
por: Yang, Changshun, et al.
Publicado: (2021)

Correction for: Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin
por: Yang, Changshun, et al.
Publicado: (2021)

Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer
por: Xu, Zongbin, et al.
Publicado: (2016)

Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
por: Choi, Ji Hoon, et al.
Publicado: (2014)

Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer
por: Shuwen, Han, et al.
Publicado: (2022)

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer
por: Chocry, Mathieu, et al.
Publicado: (2022)

Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer
por: Baba, H, et al.
Publicado: (2012)

Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis
por: Li, Xing, et al.
Publicado: (2019)

Identification of KIF21B as a Biomarker for Colorectal Cancer and Associated with Poor Prognosis
por: Xu, Shanshan, et al.
Publicado: (2022)

The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress
por: Chen, WeiQian, et al.
Publicado: (2019)

Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients
por: Shen, Yuping, et al.
Publicado: (2018)

EMBR-23. KIF11 DEPENDENCY ON P53 MUTATIONAL STATUS IN MEDULLOBLASTOMA
por: Huang, Shiying, et al.
Publicado: (2021)

Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization
por: Greenlee, Joshua D, et al.
Publicado: (2021)

Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
por: Li, Zhaopeng, et al.
Publicado: (2023)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2003)

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Alliot, C, et al.
Publicado: (2004)

Oxaliplatin (L-OHP): a new reality in colorectal cancer.
por: Bleiberg, H.
Publicado: (1998)

Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
por: Sagar, Jayesh, et al.
Publicado: (2009)

WBSCR22 confers oxaliplatin resistance in human colorectal cancer
por: Yan, Dongmei, et al.
Publicado: (2017)

Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer
por: Park, Sun Young, et al.
Publicado: (2022)

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14(ARF)-Mediated Sustained p53 Activation
por: Tomicic, Maja T., et al.
Publicado: (2021)

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer
por: Hsieh, Chi-Che, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer
por: Chang, Ching-Wei, et al.
Publicado: (2020)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

Upregulation of KIF20A correlates with poor prognosis in gastric cancer
por: Sheng, Yi, et al.
Publicado: (2018)

Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer
por: Zhang, Bo, et al.
Publicado: (2021)

Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis
por: Matsumoto, Yoshiko, et al.
Publicado: (2018)

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells
por: Temmink, O H, et al.
Publicado: (2007)

Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2004)

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
por: Arango, D, et al.
Publicado: (2004)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qbama3k8ui6d5cu5aa2rafne50